v3.25.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Millions
Total
Fixed Rate Perpetual Noncumulative Convertible Series B
13.00% Fixed Rate Perpetual Noncumulative Convertible Series C
Series B Preferred Stock
Series C Preferred Stock
Preferred Stock (Par Value: $0.01)
Common Stock (Par Value: $0.01)
Common Stock (Par Value: $0.01)
Series B Preferred Stock
Common Stock (Par Value: $0.01)
Series C Preferred Stock
Paid-in Capital in excess of Par
Paid-in Capital in excess of Par
Series B Preferred Stock
Paid-in Capital in excess of Par
Series C Preferred Stock
(Accumulated deficit)/Retained Earnings
Treasury Stock, at Cost
Accumulated Other Comprehensive Loss, Net of Tax
Beginning balance (in shares) at Dec. 31, 2022 227,072,445                            
Beginning balance at Dec. 31, 2022 $ 8,824         $ 503 $ 2     $ 8,135     $ 1,041 $ (237) $ (620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance and exercise of stock (in shares) 13,010,668                            
Issuance and exercise of stock $ 85           0     85          
Shares issued for restricted stock, net of forfeitures (in shares) 1,024,855                            
Shares issued for restricted stock, net of forfeitures $ 0                 (31)       31  
Compensation expense related to restricted stock awards 47                 47          
Net loss (79)                       (79)    
Dividends paid on common stock (486)                       (486)    
Dividends paid on preferred stock $ (33)                       (33)    
Purchase of common stock (in shares) (419,178)                            
Purchase of common stock $ (12)                         (12)  
Other comprehensive (loss) income, net of tax $ 21                           21
Ending balance (in shares) at Dec. 31, 2023 240,688,790                            
Ending balance at Dec. 31, 2023 $ 8,367         503 2     8,236     443 (218) (599)
Beginning balance at Dec. 31, 2022 0                            
Ending balance at Dec. 31, 2023 $ 0                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of mezzanine preferred stock Series , net (in shares)   0 0                        
Issuance and exercise of stock (in shares) 25,543,655     63,770,655 85,435,619                    
Issuance and exercise of stock $ 102     $ 258 $ 342     $ 1 $ 1 102 $ 257 $ 341      
Issuance of warrants to purchase common shares (in shares) 0                            
Issuance of warrants to purchase common shares $ 302                 302          
Shares issued for restricted stock, net of forfeitures (in shares) (16,633)                            
Shares issued for restricted stock, net of forfeitures $ 0                 (10)       10  
Compensation expense related to restricted stock awards 54                 54          
Net loss (1,118)                       (1,118)    
Dividends paid on common stock (53)                       (53)    
Dividends paid on preferred stock $ (35)                       (35)    
Purchase of common stock (in shares) (487,458)                            
Purchase of common stock $ (11)                         (11)  
Other comprehensive (loss) income, net of tax $ (41)                           (41)
Ending balance (in shares) at Dec. 31, 2024 414,934,628                            
Ending balance at Dec. 31, 2024 $ 8,167         503 4     9,282     (763) (219) (640)
Preferred Stock Mezzanine (Par Value: $0.01)                              
Issuance of mezzanine preferred stock Series , net   $ 258 $ 346                        
Issuance of common shares for the conversion of Series B/ C preferred, net       $ (257) $ (346)                    
Ending balance at Dec. 31, 2024 $ 1                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Shares issued for restricted stock, net of forfeitures (in shares) 1,962,003                            
Shares issued for restricted stock, net of forfeitures $ (1)                 (40)       39  
Compensation expense related to restricted stock awards 61                 61          
Net loss (177)                       (177)    
Dividends paid on common stock (15)                       (15)    
Dividends paid on preferred stock $ (33)                       (33)    
Purchase of common stock (in shares) (914,595)                            
Purchase of common stock $ (10)                         (10)  
Other comprehensive (loss) income, net of tax $ 151                           151
Ending balance (in shares) at Dec. 31, 2025 415,982,036                            
Ending balance at Dec. 31, 2025 $ 8,143         $ 503 $ 4     $ 9,303     $ (988) $ (190) $ (489)
Ending balance at Dec. 31, 2025 $ 1